Thought Leadership

Explore published articles, interviews, and blog posts from leading IP professionals.

Search results
Blog | August 27, 2015

BPCIA Dance Partners Request En Banc Rehearing and Amgen Seeks Temporary Injunction

Read more
Article | August 12, 2015

Process Patents Are Vital In Biotech — Why Not Extend Them?

Read more
Blog | July 27, 2015

Judicial Review Available for Decision that a Patent Qualified for CBM Review; § 101 Review Appropriate in CBM Review

Read more
Blog | July 24, 2015

PTAB's Construction Must Be "Reasonable" In Light of All Intrinsic Evidence, PTAB May Require Patentee to Show Amended Claims Are Patentable Over All Prior Art of Record

Read more
Blog | July 24, 2015

District Courts Deciding Whether to Modify a Protective Order to Allow U.S. Discovery to Be Used in Foreign Litigation Must Consider Factors Relevant to Section 1782 Proceedings

Read more
Article | July 23, 2015

How To Avoid FDA Regulation Of Your Mobile Medical App

Read more
Blog | July 22, 2015

Amgen v. Sandoz: Federal Circuit Weighs In on the BPCIA Riddle

Read more
Blog | July 21, 2015

Exclusion of Patentee's Damages Expert Not Sufficient to Justify Granting Summary Judgment

Read more
Blog | July 21, 2015

Claims Should Be Broadly Construed to Include Their Full Plain Meaning Where There Is No Disclaimer or Lexicography

Read more
Blog | July 08, 2015

Software Claim Addressing Concepts Long Known in Other Fields and Lacking Other Inventive Concept Is Not Patent Eligible

Read more
Blog | July 07, 2015

FDA's Latest ANDA Guidance: Patent Carve Outs Become a Guessing Game

Read more
Blog | July 06, 2015

35 U.S.C. § 101 Practice in the Eastern District of Texas

Read more